
Melanoma



April 17, 2023
Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma
The ASCO Post

September 19, 2023
Previously Untreated Advanced Melanoma: Addition of Bempegaldesleukin to Nivolumab
The ASCO Post

January 05, 2024
Rare T Cells May Help Predict Immunotherapy Response in Patients With Skin Cancer
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.

August 05, 2024
FDA Grants Accelerated Approval to T-Cell Therapy for Unresectable or Metastatic Synovial Sarcoma
The ASCO Post

August 12, 2024
Pattern in Protein Production May Be Predictive of Side Effects From Immunotherapy in Patients With Melanoma
The ASCO Post

January 02, 2025
FDA Approves Nivolumab and Hyaluronidase-nvhy for Subcutaneous Injection
The ASCO Post

August 21, 2023
Ipilimumab Plus Nivolumab May Improve Outcomes in Patients With Refractory Metastatic Melanoma, Study Suggests
The ASCO Post
Advertisement
Recommendations
Advertisement